Riegel v. Medtronic, Inc.
http://dbpedia.org/resource/Riegel_v._Medtronic,_Inc. an entity of type: Thing
Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the bars state common-law claims that challenge the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration. It modified the rule in Medtronic, Inc. v. Lohr.
rdf:langString
rdf:langString
Riegel v. Medtronic, Inc.
rdf:langString
rdf:langString
Charles R. Riegel, et ux. v. Medtronic, Inc.
xsd:integer
15953555
xsd:integer
1026035177
rdf:langString
Ginsburg
xsd:integer
6
rdf:langString
Roberts, Kennedy, Souter, Thomas, Breyer, Alito; Stevens
<second>
172800.0
xsd:integer
312
xsd:integer
552
xsd:gMonthDay
--12-04
xsd:integer
2007
rdf:langString
Riegel v. Medtronic, Inc.,
xsd:gMonthDay
--02-20
xsd:integer
2008
rdf:langString
Charles R. Riegel, et ux. v. Medtronic, Inc.
rdf:langString
The MDA’s pre-emption clause bars common-law claims challenging the safety or effectiveness of a medical device marketed in a form that received premarket approval from the FDA.
rdf:langString
Riegel v. Medtronic, Inc.
rdf:langString
Scalia
rdf:langString
Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the bars state common-law claims that challenge the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration. It modified the rule in Medtronic, Inc. v. Lohr.
rdf:langString
Stevens
xsd:nonNegativeInteger
2451